Supercharging a New FDA: Marty Makary on Science, Power & Patients - All-In with Chamath, Jason, Sacks & Friedberg Recap

Podcast: All-In with Chamath, Jason, Sacks & Friedberg

Published: 2026-01-15

Duration: 1 hr 30 min

Summary

Dr. Marty Makary discusses his transformative approach to the FDA, emphasizing the need for faster drug approvals, transparency, and rebuilding public trust in health institutions post-COVID.

What Happened

In this episode, Dr. Marty Makary, the FDA Commissioner, shares insights on his journey to the role and his vision for the agency. He reflects on his previous experiences, including advocating for price transparency in healthcare, which led to his involvement with the Trump administration. Makary highlights the significant reforms implemented during his tenure, including 42 major changes aimed at expediting drug approvals and improving transparency within the FDA. He asserts that the outdated timeline for new drug approvals, which often spans 10 to 12 years, is unacceptable and that the agency must challenge its status quo to provide timely healthcare solutions.

Makary also addresses the controversies and pushback surrounding his leadership style, particularly from those who have left the FDA. He emphasizes that while some critics cite chaos and turmoil, he believes that rapid progress is essential in government. He notes that despite restructuring, the FDA has maintained stable employee turnover rates and is actively hiring new scientists to meet ambitious goals. The conversation shifts to the competitive landscape in biotechnology, especially the race against China, where Makary acknowledges that the U.S. is at a critical juncture in maintaining its innovation leadership. He stresses the urgency of acting to keep pace with international advancements in biotech.

Key Insights

• Dr. Makary emphasizes the need for radical reforms in the FDA to improve drug approval timelines.
• Transparency is a key focus, with public access to rejection letters enhancing accountability.
• The COVID-19 pandemic highlighted flaws in public health messaging and the need for scientific rigor.
• The U.S. is facing a competitive challenge from nations like China in the biotechnology sector.

Key Questions Answered

How did Dr. Makary get involved with the FDA?

Dr. Makary's journey to the FDA began with his background in academia and clinical practice at Johns Hopkins. His focus on healthcare system problems, particularly price transparency, led him to author a successful book that caught the attention of the White House. This connection resulted in significant discussions during the Trump administration, ultimately leading to his appointment as FDA Commissioner.

What major reforms has Dr. Makary implemented at the FDA?

Since taking office, Dr. Makary has announced 42 major reforms aimed at improving the FDA's efficiency and transparency. These reforms challenge the long-standing timeline of 10 to 12 years for drug approvals and aim to create new pathways and priority reviews to expedite the process. Additionally, there have been initiatives to make rejection letters public, fostering greater accountability.

What challenges has Dr. Makary faced from FDA staff?

Dr. Makary acknowledges that his leadership style and the rapid changes at the FDA have faced pushback from some employees who have left the agency. Critics have described the environment as chaotic, but he argues that meaningful progress often comes with disruption. He emphasizes that the FDA's turnover rates remain stable and that the agency is committed to building a positive culture and expanding its workforce.

How does Dr. Makary view the U.S. biotechnology landscape compared to China?

Dr. Makary asserts that there is indeed a race in biotechnology, and he believes the U.S. has been falling behind. He cites a Congressional report indicating that Chinese companies are rapidly increasing their share of licensing deals and scientific publications. He stresses the urgency for the U.S. to act decisively to maintain its leadership in biotech innovation.

What is Dr. Makary's vision for the future of public health?

Dr. Makary's vision for public health centers on restoring trust in health institutions and prioritizing rapid access to cures and treatments. He aims to shift the focus from fighting misinformation to delivering tangible health benefits to the American public, particularly through an emphasis on healthier food options for children and accelerated drug development.